| Website | variationbiotech.com |
| Category | BioTech |
| Phone | 617-949-2270 |
| Employees |
| TOTAL | $35.7M |
| VENTURE FUNDING TOTAL | $35.7M |
| Series A, 1/07 Clarus Ventures ARCH Venture Partners 5AM Ventures | $35.7M |
| DEBT TOTAL | $7.8M |
| Debt, 7/11 | $7.8M |
Variation Biotechnologies (VBI) is a leader in the discovery and development of novel vaccines to fight infectious diseases, including seasonal and pandemic influenza, hepatitis and HIV. The company utilizes its proprietary Variosite™ to design vaccines with broad immunity, and is also developing proprietary formulation technologies to enable convenient oral administration. VBI’s lead candidates include a parenteral vaccine to fight influenza and an orally-delivered vaccine to address hepatitis A.
